5604 results
Refine Your Search
Research Now: New Research on COVID & Blood Cancer
The transcript and FAQ below provide additional information for participants in the webinar LLS Research Now: NEW Research on COVID & Blood Cancer, he…
Alesia
In November , I experienced my first panic attack while at work. I went to the urgent care clinic, and they tested me and said I was good and might be…
Amanda
I am now a acute myeloid leukemia (AML) survivor. When I was diagnosed with AML, it was an absolute complete shock. At the time of my diagnosis, I wa…
Brent
My nephew Brent Terence was a perfectly healthy - young man, active in school, on his routine , and had normal labs. But until the end of July , Tere…
Grace
I went to a simple doctor's appointment on October , and from that day on, my life flipped upside down. I was diagnosed with acute lymphoblastic leuke…
Heriberto
I was diagnosed with Burkitt lymphoma (BL) on Friday the 13th ― August , , to be exact ― seven months after being married, three months after my weddi…
Stories
Jim
Stay focused, stay positive, live as life as normally as you did before diagnosis, and do your best. I was diagnosed with chronic lymphocytic l…
Jonathan
I’ll start from the beginning.In , I was diagnosed with testicular cancer. I had surgery to remove the mixed germ cell tumor and then was on the road …
Winter
In July , I began to notice that I was not feeling like myself. I became tired very easily, and keeping up with my children was increasingly difficult…
Jonathan
I was diagnosed with diffused large lymphoma (DLBCL) with concentrations in the brain and lungs. Lymphoma itself is a cancer that starts in the cells…
Elisabeth
I was first diagnosed at years old with stage Hodgkin lymphoma, a blood cancer. I didn’t even know what the word cancer meant. I remember sitting at…
Stories
YAconnect: Young Adults Living with Leukemia, Lymphoma and Myeloma
Tak Mak
Tak W. Mak is an international leader in cancer and immunology research. He is best known for his cloning of the human T cell receptor in , which led …
The Immune Niche in the Development of Hematological Malignancies and Implications for Novel Therapy
Our SCOR Program, composed of four complementary Projects supported by three shared Cores, is designed to determine how the immune niche and factors i…
Spotlight On Myeloproliferative Neoplasms (MPNs)
Topics CoveredWe invite you to learn more about:The different types of Myeloproliferative Neoplasms (MPNs)Therapies for MPNsCurrent research and clini…
Education Resources
Crucial LLS Support Drives Approval of New Precision Medicine for Rare Group of Blood Diseases
The U.S. Food and Drug Administration (FDA) this week approved cobimetinib (Cotellic®), a precision medicine treatment for adults with any of a family…
LLS Applauds FDA Approval of New Treatment Option for Pediatric Patients with Hodgkin Lymphoma
The U.S. Food and Drug Administration (FDA) yesterday approved brentuximab vedotin (Adcetris®) in combination with standard chemotherapy in children …
News Release
The Leukemia & Lymphoma Society Earns a Four-Star Rating From Charity Navigator
The Leukemia & Lymphoma Society is proud to announce that because of its strong financial health and ongoing accountability and transparency, LLS has …
News Release
Matt
On February 2nd, my youngest daughter, Harper, was diagnosed with leukemia. Three and a half years later as I'm writing this I have a lump in my thro…
Blood Cancer 101: The Basics on Disease, Treatment, and the Role of the HCP
This activity is intended for oncology social workers, psychologists, nurses, and other healthcare professionals involved in the care of patients with…
Other
The Leukemia & Lymphoma Society’s Presence at ASH Showcases Progress to Advance Cures and Care for Blood Cancer Patients
At the 64th Annual American Society of Hematology (ASH) Annual Meeting (December -), The Leukemia & Lymphoma Society (LLS) will be presenting new rese…
News Release
TAP Partner News During SITC: Nov 2022
Current and former TAP partners presented new data during the The Society for Immunotherapy of Cancer (SITC) meeting that took place from November -1…
TAP Partner News During ASH: Dec 2022
Current and former TAP partners presented new data during the American Society of Hematology (ASH) meeting that took place from December -13th.
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track Designations to CB-010, an Allogeneic Anti-CD19 CAR-T Cell Therapy
BERKELEY, Calif., Nov. , - Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading CRISPR biopharmaceutical company, today announced that the U.S. Food…
News Release
X4 Pharmaceuticals Announces Positive Top-Line Results from 4WHIM Global, Pivotal Phase 3 Trial of Once-Daily, Oral Mavorixafor in WHIM Syndrome
BOSTON, Nov. , - X4 Pharmaceuticals (Nasdaq: XFOR), a leader in the discovery and development of novel therapeutics to benefit people with diseases…